Tranexamic Acid Failed to Reverse the Anticoagulant Effect and Bleeding by an Oral Direct Factor Xa Inhibitor Edoxaban.

about

Tranexamic Acid Failed to Reverse the Anticoagulant Effect and Bleeding by an Oral Direct Factor Xa Inhibitor Edoxaban.

Item

http://www.wikidata.org/entity/Q50050577

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@en

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@nl

type

Item

label

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@en

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@nl

prefLabel

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@en

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@nl

P1476

Tranexamic Acid Failed to Reve ...... Factor Xa Inhibitor Edoxaban.

@en

P2093

Taketoshi Furugohri

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Morishima

http://www.w3.org/2001/XMLSchema#string

Yuko Honda

http://www.w3.org/2001/XMLSchema#string

P2860

Edoxaban versus warfarin in patients with atrial fibrillation

Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

Tranexamic acid--an old drug still going strong and making a revival.

DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles.

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.

The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxaban.

Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.

Aminocaproic Acid and Tranexamic Acid Fail to Reverse Dabigatran-Induced Coagulopathy.

P304

92-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000484172

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29131074

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation